Le Lézard
Classified in: Health, Science and technology
Subjects: Photo/Multimedia, Personnel

CG Life Bolsters Strategic Capabilities With Addition of Chris Weber as Senior Vice President of Strategy


CG Life, a leading integrated agency that blends strategic creative, marketing, digital, and communications with science, has welcomed Chris Weber as the agency's Senior Vice President of Strategy. Weber brings three decades of healthcare agency experience to the role, where he will be responsible for broadening CG Life's strategic offering and working closely with clients, especially those in biopharma, to help grow their businesses.

"CG Life is at a very pivotal and exciting growth stage, and Chris' addition to the team is instrumental in helping us forge strong partnerships with our biopharma and life science clients through enhanced strategic capabilities," said David Ormesher, CG Life CEO. "He is a true rock star with that intangible blend of experience, smarts, and leadership that is indispensable to entrepreneurial companies like CG Life. I'm thrilled to have him on board."

Over the course of his career, Weber has held several senior agency leadership positions, most recently with Eversana Intouch as well as Merge and CorbettAccel Healthcare Group, where he focused on addressing client issues by developing unique and effective strategies to drive business growth. He also spent 13 years as an award-winning copywriter and creative director.

"I'm impressed with CG Life's commitment to growing its capabilities to meet client needs, and I look forward to contributing to the agency's strategic offering, specifically in the complex biopharma arena," Weber said. "This new role connects my passion and experience as a strategic leader with CG Life's deep scientific acumen to bring business-building solutions to both current and new clients."

For more than two decades, CG Life has provided integrated marketing solutions to companies leading the way in biopharma, medical devices, diagnostics, and research tools and services. The company recently introduced a rebrand that reflects its core commitment to being "shaped by science," which underscores how everything it does with client partners is shaped by the profound impact of science on everyday lives.

About CG Life

For established and aspiring leaders in life science and healthcare, CG Life is the integrated marketing communications partner that grows organizations, improves outcomes, and elevates brands by combining science and creativity like no other. Since 2003, CG Life has blended scientific understanding with strategic imagination to guide clients through the biggest leaps they make.


These press releases may also interest you

at 00:00
XSOOH has always been at the forefront of hair care innovation, striving to deliver cutting-edge  products  that enhance the way customers achieve their desired looks. In a world where time is precious, XSOOH  proudly announces the launch of the...

3 jui 2024
In a landmark event signaling its ambitious foray into the biopharmaceutical sector, LOTTE BIOLOGICS, under the leadership of CEO Richard W. Lee, held a groundbreaking ceremony for its inaugural plant at the Songdo Bio Campus in Incheon International...

3 jui 2024
On June 29, the "Gather Great Wisdom to Shape the Future of Intelligent Manufacturing?Special Exhibition on Design Intelligence and High Quality Development", hosted by the China Academy of Art (CAA), opened at the National Museum of China in...

3 jui 2024
Intermap Technologies ("Intermap" or the "Company"), a global leader in 3D geospatial products and intelligence solutions, announces a new financing. The Company is offering up to a maximum of 4,300,000 Class "A" common shares of the Company...

3 jui 2024
"The Classic Quotes by Xi Jinping," a multilingual TV show produced by China Media Group, aired in Kazakhstan on Tuesday after Chinese...

3 jui 2024
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...



News published on and distributed by: